Search research articles
Contact Us
Filters
Showing results (141-150 of 256) with videos related to
Page
of 26
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 1, 1994
Clinical pharmacodynamics of continuous infusion topotecan in children: systemic exposure predicts hematologic toxicity
C F Stewart, S D Baker, R L Heideman, et al.
Investigational New Drugs
|
January 1, 1995
A phase I study of sulofenur in refractory pediatric malignant solid tumors
C B Pratt, L C Bowman, N Marina, et al.
Journal of Pediatric Hematology/Oncology
|
April 25, 2000
Comparative renal tubular toxicity of chemotherapy regimens including ifosfamide in patients with newly diagnosed sarcomas
N M Marina, C A Poquette, A M Cain, et al.
Journal of Pharmaceutical Sciences
|
November 1, 1981
Pharmacokinetics of sustained serum methotrexate concentrations secondary to gastrointestinal obstruction
W E Evans, A Tsiatis, W R Crom, et al.
Cancer
|
November 1, 1977
Colorectal carcinoma in adolescents implications regarding etiology
C B Pratt, G Rivera, E Shanks, et al.
Pediatric Blood & Cancer
|
September 25, 2004
Tumor size as a predictor of outcome in pediatric non-metastatic osteosarcoma of the extremity
Sue C Kaste, T Liu, C A Billups, et al.
American Journal of Clinical Oncology
|
December 1, 1991
Phase I study of flavone acetic acid (NSC 347512, LM975) in patients with pediatric malignant solid tumors
C B Pratt, M V Relling, W H Meyer, et al.
Orthopedics
|
August 1, 1996
Fractures in children treated with radiotherapy for soft tissue sarcoma
J E Wall, S C Kaste, C A Greenwald, et al.
Cancer
|
January 1, 1995
Embryonal malignancies of unknown primary origin in children
J F Kuttesch, D M Parham, S C Kaste, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 1, 1992
Ifosfamide plus etoposide in newly diagnosed Ewing's sarcoma of bone
W H Meyer, L Kun, N Marina, et al.
Page
of 26
Search research articles
Search
Showing results (141-150 of 256) with videos related to
Sort By:
Page
of 26
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 1, 1994
Clinical pharmacodynamics of continuous infusion topotecan in children: systemic exposure predicts hematologic toxicity
C F Stewart, S D Baker, R L Heideman, et al.
Investigational New Drugs
|
January 1, 1995
A phase I study of sulofenur in refractory pediatric malignant solid tumors
C B Pratt, L C Bowman, N Marina, et al.
Journal of Pediatric Hematology/Oncology
|
April 25, 2000
Comparative renal tubular toxicity of chemotherapy regimens including ifosfamide in patients with newly diagnosed sarcomas
N M Marina, C A Poquette, A M Cain, et al.
Journal of Pharmaceutical Sciences
|
November 1, 1981
Pharmacokinetics of sustained serum methotrexate concentrations secondary to gastrointestinal obstruction
W E Evans, A Tsiatis, W R Crom, et al.
Cancer
|
November 1, 1977
Colorectal carcinoma in adolescents implications regarding etiology
C B Pratt, G Rivera, E Shanks, et al.
Pediatric Blood & Cancer
|
September 25, 2004
Tumor size as a predictor of outcome in pediatric non-metastatic osteosarcoma of the extremity
Sue C Kaste, T Liu, C A Billups, et al.
American Journal of Clinical Oncology
|
December 1, 1991
Phase I study of flavone acetic acid (NSC 347512, LM975) in patients with pediatric malignant solid tumors
C B Pratt, M V Relling, W H Meyer, et al.
Orthopedics
|
August 1, 1996
Fractures in children treated with radiotherapy for soft tissue sarcoma
J E Wall, S C Kaste, C A Greenwald, et al.
Cancer
|
January 1, 1995
Embryonal malignancies of unknown primary origin in children
J F Kuttesch, D M Parham, S C Kaste, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 1, 1992
Ifosfamide plus etoposide in newly diagnosed Ewing's sarcoma of bone
W H Meyer, L Kun, N Marina, et al.
Page
of 26